Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Yunkang Group Limited ( (HK:2325) ) has provided an announcement.
Yunkang Group Limited has announced the appointment of Dr. Dong Min as an independent non-executive director, effective April 10, 2025. Dr. Dong brings extensive experience in biomedicine, having held senior positions at notable companies such as Novartis and Clover Biopharmaceuticals. Her appointment is expected to enhance the company’s strategic direction and governance, potentially impacting its market positioning positively.
More about Yunkang Group Limited
YTD Price Performance: -63.74%
Average Trading Volume: 173,385
Technical Sentiment Signal: Strong Buy
Current Market Cap: HK$2.08B
For detailed information about 2325 stock, go to TipRanks’ Stock Analysis page.